Catalysts
Catalysts — What Can Move the Stock
Catalyst Setup
The next six months hinge on a single observable signal: whether China's NDRC/MIIT/SAMR ministries enforce a polysilicon minimum-price framework around June 2026. Management has explicitly anchored the entire forward narrative — and the deliberate Q1 2026 sales freeze that cost $98M in inventory impairment — on a "wait-and-see" bet that an updated cost model and price-law guidance lands "around June." The CFO has stated, on tape, that if no enforcement materializes the company will "lower utilization and start to sell at close to market pricing," which is the formal capitulation signal. Everything else on the calendar — Q2 results in late August, the unspent $100M buyback, the Continental General 9.9% activist position, competitor balance-sheet stress — derives its weight from how the June policy event resolves. The calendar is one-event-heavy: thin on hard dates, fat on a single binary.
Hard-Dated Events (6m)
High-Impact Catalysts
Next Hard Date (days)
Signal Quality (1–5)
Calendar quality: Medium-Thin. Only two genuinely hard-dated events sit in the next six months (Q2 2026 results in late August, Q3 2026 results in late October — both inferred from the company's own historical reporting cadence: Q2 2025 was Aug 26, Q3 2025 was Oct 27). The dominant catalyst is a soft-window policy decision that management itself has framed as binary and time-bound. Stock direction will be driven by a regulatory announcement Daqo does not control, not by anything reported on an earnings call.
Ranked Catalyst Timeline
The list below ranks by decision value, not chronology. Three policy/competitor signals dominate; two earnings dates are placeholders that derive their meaning from the policy outcome.
Date verification. Earnings dates above are derived from Daqo's own historical reporting cadence (Q2 2025 results: Aug 26, 2025; Q3 2025 results: Oct 27, 2025; Q4 2025 results: Feb 26, 2026; Q1 2026 results: Apr 29, 2026). The company has not formally pre-announced Q2 2026 or Q3 2026 dates. The "June 2026" anti-involution window is management's own language on the Q1 2026 call ("expects updated cost-model and price guidance from authorities around June").
Impact Matrix
The matrix below isolates the catalysts that actually resolve the bull/bear debate, rather than just adding information. Three of the five anchor on the same single underlying variable: realized polysilicon ASP and the regulatory framework that sets it.
Next 90 Days
The next 90 days are watchpoint-heavy and event-light. There is no scheduled earnings release inside this window — the Apr 29 print is the freshest data, and Q2 2026 results are not expected until late August. The decision-relevant items are observable signals on policy, peer behavior, and the tape.
No scheduled earnings event in the next 90 days. The next hard-dated company release is the Q2 2026 print, expected late August 2026 based on Daqo's reporting cadence (Q2 2025 was Aug 26, Q2 2024 was Jul 31, Q2 2023 was Aug 14). For the 90-day horizon, the stock is mechanically more sensitive to a regulatory announcement and a competitor”s capital decision than to anything Daqo itself will say.
What Would Change the View
The investment debate over the next six months collapses into three observable signals, listed in order of how decisively each would force the debate to update. First and dominant: the form of the June 2026 anti-involution decision. A named-enforcement framework with a minimum price at or above ~RMB 50/kg converts Daqo from a book-floor story to a mid-cycle multiple story — directly resolving the bull thesis (Numbers' base case) and falsifying the bear thesis (the "Beijing put never arrives" claim). A face-saving "guidance" without teeth confirms the bear and triggers the CFO's stated fallback of selling at market, which mechanically accelerates cash burn. Second: a named competitor exit — a multi-billion-RMB impairment from Tongwei, GCL, Xinte, or Asia Silicon, or any restructuring filing — is the bear's explicit cover signal and the bull's "consolidation-related investment" trigger; either way it converts the trough from balance-sheet endurance into rationalized capacity. Third: meaningful parent-level execution of the $100M buyback — particularly above $25M and at sub-book prices — would test management's alignment publicly and remove the largest soft criticism on the People grade. If none of these three signals print over the next two quarters, the calendar reverts to a continuous watchpoint regime: weekly polysilicon RMB prints and quarterly cash-position updates, with the next real decision point pushed to the Q3 2026 earnings call in late October.